(Q34045311)

30 July 2017

1 reference

title

The metabolic effects of cyclosporin and tacrolimus (English)

1 reference

30 July 2017

Marchetti P

1

1 reference

30 July 2017

Navalesi R

series ordinal

2

1 reference

30 July 2017

publication date

1 July 2000

1 reference

Journal of Endocrinological Investigation

30 July 2017

published in

1 reference

30 July 2017

volume

23

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

482-490

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03343761

30 July 2017

exact match

0 references

cites work

Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Post-transplant diabetes mellitus. The role of immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Insulin action and insulin binding following pancreas transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Clinical use of the euglycemic hyperinsulinemic clamp for diagnosis of tacrolimus-induced insulin resistance after combined pancreas-kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Mechanism of the diabetogenic action of cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Effect of cyclosporin treatment on metabolic and hormonal responses to mixed meal plus oral glucose in dogs with intrasplenic pancreatic islet autograft.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Cyclic ADP-ribose binds to FK506-binding protein 12.6 to release Ca2+ from islet microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Pharmacokinetic Optimisation of Oral Hypoglycaemic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Possible interaction between cyclosporine and glibenclamide in posttransplant diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Impact of long-term immunosuppression with cyclosporin A on serum lipids in stable renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Hyperlipidaemia in renal transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

A randomised, prospective study on the conversion from cyclosporine-prednisone to cyclosporine-azathioprine at 6 months after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Carotid atherosclerosis in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Graft coronary vasculopathy in cardiac transplantation--evaluation of risk factors by multivariate analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Cardiac transplant coronary artery disease. A multivariable analysis of pretransplantation risk factors for disease development and morbid events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Early development of accelerated graft coronary artery disease: risk factors and course

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Carotid atherosclerosis in renal transplant recipients: relationships with cardiovascular risk factors and plasma lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Cardiovascular risk factors and diseases after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Chemotaxis of the monocyte cell line U937: Dependence on cholesterol and early mevalonate pathway products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

The biguanide compound metformin prevents desensitization of human pancreatic islets induced by high glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343761

Troglitazone, a new antidiabetic agent, decreases cyclosporine level

21 January 2018

1 reference

12 December 2020

Cholestatic effects of cyclosporine in the rat

1 reference

12 December 2020

Effect of therapy with deflazacort on dyslipoproteinemia after pediatric renal transplantation

1 reference

12 December 2020

Decreased postheparin lipolytic activity in renal transplant recipients with cyclosporin A

1 reference

12 December 2020

Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients.

1 reference

12 December 2020

Dose-dependent suppression of transplant arteriosclerosis in aorta-allografted, cholesterol-clamped rabbits. Suppression not eliminated by the cholesterol-raising effect of cyclosporine

1 reference

12 December 2020

Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects

1 reference

12 December 2020

Effects of cyclosporin on cholesterol 27-hydroxylation and LDL receptor activity in HepG2 cells

1 reference

12 December 2020

Hypercholesterolemia in long-term survivors of heart transplantation: an early marker of accelerated coronary artery disease

1 reference

12 December 2020

Morphological and functional changes of islets of Langerhans in FK506-treated rats

1 reference

12 December 2020

Interaction between glipizide and cyclosporine: report of two cases

1 reference

12 December 2020

Cyclosporin suppresses transplant arteriosclerosis in the aorta-allografted, cholesterol-clamped rabbit. Suppression preceded by decrease in arterial lipoprotein permeability

1 reference

12 December 2020

Biliary secretion of bile acids, lipids, and bilirubin by the transplanted liver. A quantitative study in patients on cyclosporine

1 reference

12 December 2020

Effects of cyclosporin on insulin and C-peptide secretion in healthy beagles

1 reference

12 December 2020

Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets

1 reference

12 December 2020

Efficacy and Pharmacokinetics of Simvastatin in Heart Transplant Recipients

1 reference

12 December 2020

Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients

1 reference

12 December 2020

Immunocytochemical and ultrastructural changes of islet cells in rats treated long-term with cyclosporine at immunotherapeutic doses

1 reference

12 December 2020

Cotranslational inhibition of apoB-100 synthesis by cyclosporin A in the human hepatoma cell line HepG2.

1 reference

12 December 2020

Cyclosporin A trough levels correlate with serum lipoproteins and apolipoproteins: implications for therapeutic drug monitoring of cyclosporin A

1 reference

12 December 2020

Effects of cyclosporine on insulin secretion and insulin sensitivity in dogs with intrasplenic islet autotransplants

1 reference

12 December 2020

Efficacy and muscle safety of fluvastatin in cyclosporine-treated cardiac and renal transplant recipients: an exercise provocation test

1 reference

12 December 2020

Long-term outcome of a prospective trial of steroid withdrawal after kidney transplantation

1 reference

12 December 2020

Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation

1 reference

12 December 2020

Immunosuppressive therapy

1 reference

12 December 2020

Direct effects of cyclosporin A on human pancreatic beta-cells

1 reference

12 December 2020

Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation

1 reference

12 December 2020

Effect of fluvastatin on lipoprotein profiles in treating renal transplant recipients with dyslipoproteinemia

1 reference

12 December 2020

The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.

1 reference

12 December 2020

Hyperlipidemia and glucose intolerance in the post-renal transplant patient

1 reference

12 December 2020

Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation

1 reference

12 December 2020

Hyperlipidaemia in renal transplantation—risk factor for long‐term graft outcome

1 reference

12 December 2020

The beneficial effects of steroid withdrawal on blood pressure and lipid profile in children posttransplantation in the cyclosporine era.

1 reference

12 December 2020

Risk factor analysis for the major hazards following heart transplantation--rejection, infection, and coronary occlusive disease

1 reference

12 December 2020

[Rhabdomyolysis caused by simvastatinin a patient following heart transplantation and cyclosporine therapy]

1 reference

12 December 2020

Renal allograft rejection. Possible involvement of antibody-dependent cell-mediated cytotoxicity

1 reference

12 December 2020

Cyclosporine treatment reduces early atherosclerosis in the cholesterol-fed rabbit

1 reference

12 December 2020

Cyclosporin A and islet function

1 reference

12 December 2020

Relevance of conventional cardiovascular risk factors for the prediction of coronary artery disease in diabetic patients on renal replacement therapy

1 reference

12 December 2020

Effect of fluvastatin for safely loweringatherogenic lipids in renal transplant patients receiving cyclosporine

1 reference

12 December 2020

In vitro effects of FK-506 on human and rat islets

1 reference

12 December 2020

Recovery and hypersecretion of insulin and reversal of insulin resistance after withdrawal of short-term cyclosporine treatment

1 reference

12 December 2020

Mechanisms of action of cyclosporin A on islet alpha- and beta-cells. Effects on cAMP- and calcium-dependent pathways

1 reference

12 December 2020

Studies on structural changes of the carotid arteries and the heart in asymptomatic renal transplant recipients

1 reference

12 December 2020

Lipoprotein Levels and Post-Heparin Lipase Activities in Kidney Transplant Recipients: Ciclosporin- versus Non-Ciclosporin-Treated Patients

1 reference

12 December 2020

Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: a randomized study

1 reference

12 December 2020

Metabolic effects of cyclosporin A and FK 506 in liver transplant recipients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03343761

1 reference

Dimensions Publication ID

30 July 2017

1049879675

0 references

1 reference